Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer's disease

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Gamberger, Dragan ^a   Lavrač, Nada ^b   Srivatsa, Shantanu ^c   Tanzi, Rudolph E ^d   Doraiswamy, P Murali ^c,e  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e DUKE UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; CLUSTER ANALYSIS; COGNITIVE DEFECT; DEMENTIA; DISEASE EXACERBATION; FEMALE; HUMAN; MALE; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

AGED; ALZHEIMER DISEASE; BIOMARKERS; CLUSTER ANALYSIS; COGNITIVE DYSFUNCTION; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 85026362401     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-06624-y     Document Type: Article

References (27)

1. Cummings, J. L., Morstorf, T. & Zhong, K. Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimer's Res. Therapy. 6, 37 (2014).
2. Ringman, J. M. et al. Dominantly Inherited Alzheimer Network. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Curr Neurol Neurosci Rep. Nov 14(11), 499 (2014).
3. Dong, A. et al. Alzheimer's Disease Neuroimaging Initiative. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers. Brain. Epub ahead of print (2016).
4. Lam, B., Masellis, M., Freedman, M., Stuss, D. T. & Black, S. E. Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome. Alzheimers Res Ther. Jan 9 5(1), 1 (2013).
5. Joseph, L. et al. Taking account of between-patient variability when modeling decline in Alzheimer's disease. Am J Epidemiol. 149(10), 963-73 (1999).
6. Snyder, H. M. et al. Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative. Alzheimers Dement. 12, 1186-1196 (2016).
7. Lin, K. A. & Doraiswamy, P. M. When Mars versus Venus is not a cliché: Gender differences in the neurobiology of Alzheimer's Disease. Frontiers in Neurology. 5, 288 (2014).
8. Seshadri, S. et al. Lifetime risk of dementia and Alzheimer's disease: risk estimates in the Framingham Study. Neurology. 49, 1498-1504 (1997).
9. Hua, X. et al. Alzheimer's Disease Neuroimaging Initiative. Sex and age differences in atrophic rates: an ADNI study with 1368 MRI scans. Neurobiol Aging. 31, 1463-1480 (2010).
10. Barnes, L. L. et al. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 62, 685-691 (2005).
11. Petersen, R. C. Early diagnosis of Alzheimer's disease: is MCI too late? Curr Alzheimer Res. 6, 324-330 (2009).
12. Petersen, R. C. Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia. 15, 93-101 (2000).
13. Petersen, R. C. et al. Current concepts in mild cognitive impairment. Arch Neurol. 58, 1985-92 (2001).
14. Doraiswamy, P. M. et al. Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. Mol Psychiatry. 19, 1044-1051 (2014).
15. Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 270-279 (2011).
16. Armstrong, R. A. & Wood, L. The identification of pathological subtypes of Alzheimer's disease using cluster analysis. Acta Neuropathol. 62, 426-432 (1994).
17. Galbrun, E. & Miettinen, P. From black and white to full color: extending redescription mining outside the Boolean world. Stat Anal Data Mining. 5, 284-303 (2012).
18. Sun, S. A survey of multi-view machine learning. Neural Comput Appl. 23, 2031-2038 (2013).
19. Shi, T. & Horvath, S. Unsupervised Learning With Random Forest Predictors. Journal of Computational and Graphical Statistics 15, 118-138 (2006).
20. Pfahringer, B., Holmes, G., & Wang, C. Millions of random rules. In Workshop on Advances in Inductive Rule Learning, 15th European Conference on Machine Learning (ECML) (2004).
21. Weiner, M. W. et al. Impact of the Alzheimer's Disease Neuroimaging Initiative. 2004 to 2014. Alzheimers Dement. Jul 11(7), 865-84 (2015).
22. Spiegel, R., Berres, M., Miserez, A. R. & Monsch, A. U. Alzheimer's Disease Neuroimaging Initiative. For debate: substituting placebo controls in long-term Alzheimer's prevention trials. Alzheimers Res Ther. Mar 21 3(2), 9 (2011).
23. Gan, G., Ma, C., & Wu, J. Data Clustering: Theory, Algorithms, and Applications, SIAM, (Philadelphia, 2007).
24. Von Luxburg, U., Williamson, R. C. & Guyon, I. Clustering: Science or art? In ICML Unsupervised and Transfer Learning, 65-80 (2012).
25. Gamberger, D., Ženko, B., Mitelpunkt, A. & Lavra?, N. Homogeneous clusters of Alzheimer's disease patient population. Biomedical Engineering Online 15, S78 (2016).
26. Gamberger, D., Ženko, B., Mitelpunkt, A., Shachar, N. & Lavra?, N. Clusters of male and female Alzheimer's disease patients in the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Brain Informatics. 3, 169-179 (2016).
27. Gamberger, D., Ženko, B. & Lavra?, N. Exploratory Clustering for Patient Subpopulation Discovery. In Proc. of EFMI 2017: Informatics for Health: Connected Citizen-Led Wellness and Population Health, pp. 101-105 (2017).